Article
Presented by Michael A. O'Donnell, MD, University of Iowa, Iowa City
Adding lutetium (177Lu) vipivotide tetraxetan to SOC improves rPFS in mHSPC
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
Long-term data support radium-223 safety in mCRPC
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
RCT compares platinum/5-FU, platinum/paclitaxel in high-risk penile cancer
FDA updates in urology: May 2025
Lower-dose abiraterone offers viable alternative to standard-dose for mCRPC
Survey: New NMIBC treatments face slow uptake